Functional analysis of PCSK2 coding variants: A founder effect in the Old Order Amish population.
AIMS
In humans, noncoding variants of PCSK2, the gene encoding prohormone convertase 2 (PC2), have been previously associated with risk for and age of onset of type 2 diabetes (T2D). The aims of this study were to identify coding variants in PCSK2; to determine their possible association with glucose handling; and to determine functional outcomes for coding variants in biochemical studies.


METHODS
Exome-wide genotyping was performed on 1725 Old Order Amish (OOA) subjects. PCSK2 coding variants were tested for association with diabetes-related phenotypes. In vitro analyses using transfected human PC2-encoding constructs were performed to determine the impact of each mutation on PC2 activity.


RESULTS
We identified 10 rare missense coding variants in PCSK2 in various genomic databases. R430W (rs200711626) is greatly enriched in the OOA population (MAF 4.3%). This variant is almost twice as common (MAF 7.4%) in OOA individuals with T2D as in OOA individuals with normal or with normal/impaired glucose tolerance (MAF 3.9% and 2.9%, respectively; p=0.25 and p=0.10). In vitro experiments revealed a broadening of the pH optimum for the R430W variant, which may result in increased activity against PCSK2 substrates.


CONCLUSIONS
Although the association of the R430W variation with T2D in the OOA population did not reach significance, based upon the broadened pH profile of R430W PC2, we speculate that the presence of this substitution may result in altered processing of PCSK2 substrates, ultimately leading to increased conversion to diabetes.
['Winters|Alexandra|A|', 'Ramos-Molina|Bruno|B|', 'Jarvela|Timothy S|TS|', 'Yerges-Armstrong|Laura|L|', 'Pollin|Toni I|TI|', 'Lindberg|Iris|I|']
D000328:Adult D061365:Amish D003924:Diabetes Mellitus, Type 2 D005260:Female D018703:Founder Effect D005838:Genotype D006801:Humans D008297:Male D020125:Mutation, Missense D010641:Phenotype D045706:Proprotein Convertase 2
PCSK2 Prohormone convertase 2 Diabetes Glucose Glucagon